skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

BMC medicine, 2016-12, Vol.14 (1), p.194-194, Article 194 [Peer Reviewed Journal]

COPYRIGHT 2016 BioMed Central Ltd. ;Copyright BioMed Central 2016 ;The Author(s). 2016 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-016-0738-8 ;PMID: 27903264

Full text available

Citations Cited by
  • Title:
    Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers
  • Author: Ruscitti, Piero ; Cipriani, Paola ; Masedu, Francesco ; Iacono, Daniela ; Ciccia, Francesco ; Liakouli, Vasiliki ; Guggino, Giuliana ; Carubbi, Francesco ; Berardicurti, Onorina ; Di Benedetto, Paola ; Valenti, Marco ; Triolo, Giovanni ; Valentini, Gabriele ; Giacomelli, Roberto
  • Subjects: Adult ; Biomarkers ; Complications and side effects ; Development and progression ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Rare diseases ; Retrospective Studies ; Still's Disease, Adult-Onset - complications ; Still's Disease, Adult-Onset - diagnosis ; Still's Disease, Adult-Onset - mortality ; Young Adult
  • Is Part Of: BMC medicine, 2016-12, Vol.14 (1), p.194-194, Article 194
  • Description: Adult-onset Still's disease (AOSD) is rare inflammatory disease of unknown etiology that usually affects young adults. The more common clinical manifestations are spiking fevers, arthritis, evanescent rash, elevated liver enzymes, lymphadenopathy, hepatosplenomegaly, and serositis. The multi-visceral involvement of the disease and the different complications, such as macrophage activation syndrome, may strongly decrease the life expectancy of AOSD patients. This study aimed to identify the positive and negative features correlated with the outcome of patients. A retrospective analysis of AOSD patients prospectively admitted to three rheumatologic centers was performed to identify the clinical features present at the time of diagnosis and to predict the possible outcome. Furthermore, we investigated the as yet to be validated prognostic value of the systemic score previously proposed. One hundred consecutive AOSD patients were enrolled. The mean systemic score showed that the majority of patients had a multi-organ involvement. Sixteen patients showed different complications, mainly the macrophage activation syndrome. A strong increase of inflammatory markers was observed. All patients received steroids at different dosages, 55 patients in association with immunosuppressive drugs and 32 in association with biologic agents. Sixteen patients died during the follow-up. Regression analysis showed that the higher values of the systemic score and the presence of AOSD-related complications, assessed at the time of diagnosis, were significantly correlated with patient mortality. A prognostic impact of the systemic score of ≥ 7.0 was reported. Our study showed that a higher systemic score and the presence of AOSD-related complications at the time of diagnosis were significantly associated with mortality. Of note, a cut-off at 7.0 of the systemic score showed a strong prognostic impact in identifying patients at risk of AOSD-related death.
  • Publisher: England: BioMed Central Ltd
  • Language: English
  • Identifier: ISSN: 1741-7015
    EISSN: 1741-7015
    DOI: 10.1186/s12916-016-0738-8
    PMID: 27903264
  • Source: GFMER Free Medical Journals
    MEDLINE
    PubMed Central
    Springer Open Access Journals
    ROAD: Directory of Open Access Scholarly Resources
    ProQuest Central
    DOAJ Directory of Open Access Journals

Searching Remote Databases, Please Wait